Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Marsha Treadwell, PhD
Researcher Clinical Psychologist
Children's Hospital,
Oakland Research Institute
5700 Martin Luther King Jr Way
Oakland, California, United States
Marsha J. Treadwell, PhD, is a clinical psychologist and health services researcher with expertise in measurement development, community engagement, conducting health care quality improvement projects, evaluating programs and assessing the health related quality of life for individuals and communities.
Dr. Treadwell’s research integrates physical, behavioral and psychological processes, allowing for the identification of risk and resiliency factors and the development of more effective interventions.
Dr. Treadwell is working to broaden community support for sickle cell programs and has introduced intensive support strategies for families of children newly diagnosed with sickle cell disease. She is currently working to implement programs that identify and address barriers to quality of life and quality of care for youth and adults with sickle cell disease.
Ultimately, Dr. Treadwell’s goal is to foster a sense of empowerment and partnership in disease management, that improves overall wellbeing for patients with sickle cell disease and their families.
Representative Publications:
Emergency department utilization by Californians with sickle cell disease, 2005-2014
Self-efficacy and readiness for transition from pediatric to adult care in sickle cell disease
Development of a sickle cell disease readiness for transition assessment
Related Content
-
Managing Sickle Cell Disease as an AdultPeople with sickle cell disease (SCD) ar...
-
Paulette E. Forbes, MPH, MS, APNMs. Paulette E. Forbes serves as an inpa...
-
Patient-reported experience measure in sickle cell diseaseObjectives: To develop patient-reported...
-
Annual Sickle Cell Disease and Thalassaemia Conference (ASCAT) 2022The Annual Scientific Conference on Sick...
-
SCDAA Teams with MedicAlert Foundation to Improve Emergency Outcomes During Sickle Cell Crises[Hanover, Md., June 26, 2023] – The Si...
-
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...
-
Winthrop-University HospitalNYU Winthrop's pediatric hematologists p...